Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis

• Clara de Andrés ,

  Contributed equally to this work with: Clara de Andrés, Roseta Teijeiro

  * E-mail: claradenadres@hotmail.com

  Affiliation Department of Neurology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Roseta Teijeiro ,

  Contributed equally to this work with: Clara de Andrés, Roseta Teijeiro

  Affiliation Department of Neurology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Bárbara Alonso,

  Affiliation Department of Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Francisco Sánchez-Madrid,

  Affiliation Department of Immunology, Hospital de la Princesa, Madrid, Spain

  ⨯
• M. Luisa Martínez,

  Affiliation Department of Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Juan Guzmán de Villoria,

  Affiliation Department of Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Eduardo Fernández-Cruz,

  Affiliation Department of Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Silvia Sánchez-Ramón

  Affiliation Department of Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

  ⨯